Solid tumors with PTCH1 loss-of-function mutations

Clinical trials for Solid tumors with PTCH1 loss-of-function mutations explained in plain language.

Never miss a new study

Get alerted when new Solid tumors with PTCH1 loss-of-function mutations trials appear

Sign up with your email to follow new studies for Solid tumors with PTCH1 loss-of-function mutations, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

Targeted pill shows promise for rare genetic cancers

Disease control Completed

This study tested an experimental drug called ENV-101 (taladegib) in 20 adults with advanced solid tumors that have a specific genetic mutation (PTCH1 loss-of-function). The drug works by blocking a growth pathway in cancer cells. Researchers measured how many patients' tumors sh…

Matched conditions: SOLID TUMORS WITH PTCH1 LOSS-OF-FUNCTION MUTATIONS

Phase 2 • Sponsor: Endeavor Biomedicines, Inc. • Aim: Disease control

Last updated Jun 27, 2026 09:10 UTC

Solid tumors with PTCH1 loss-of-function mutations

Get alerted when new Solid tumors with PTCH1 loss-of-function mutations trials appear

Targeted pill shows promise for rare genetic cancers